Prodromal corticobasal syndrome (CBS) refers to the preclinical and early symptomatic phase preceding the full manifestation of classic CBS features. The prodromal period can span months to years, and early identification is crucial for timely intervention, accurate diagnosis, and appropriate clinical management.
Unlike other neurodegenerative disorders such as Parkinson's disease, CBS prodromal criteria are less well-established. However, research from the past decade has identified several early features that may signal impending CBS, particularly when associated with specific genetic risk factors or underlying pathologies.
Mild cognitive impairment: Subtle cognitive changes often precede motor symptoms by 1-3 years:
- Executive dysfunction: Difficulty with planning, multitasking, and problem-solving
- Language difficulties: Subtle word-finding difficulties, reduced verbal fluency
- Visuospatial deficits: Especially in right-hemisphere predominant cases
- Memory complaints: Often mild, not typically amnestic pattern
Asymmetric parkinsonism: Early motor manifestations that may be subtle:
- Focal hand dystonia: Particularly in the dominant hand
- Mild bradykinesia: Often asymmetric
- Myoclonus: May appear as subtle jerks, often first noticed by family
- Alien limb sensation: Some patients report early foreign limb sensations
Early neuropsychiatric features:
- Apathy (most common early feature)
- Depression and anxiety
- Irritability
- Reduced insight (anosognosia) can be early
¶ Risk Factors and Biomarkers
| Gene |
Risk |
Notes |
| MAPT |
High |
PSP/CBS overlap, 4R tau pathology |
| GRN |
High |
TDP-43 pathology, often CBS phenotype |
| C9orf72 |
Moderate |
Can present as CBS with FTD |
| APOE |
Moderate |
e4 allele may accelerate |
Neuroimaging findings:
- MRI: Subtle asymmetric frontoparietal atrophy, particularly in precentral gyrus
- FDG-PET: Hypometabolism in contralateral frontoparietal regions
- Tau PET: Variable, may show focal uptake in motor cortex
Fluid biomarkers:
- Neurofilament light chain (NfL): Elevated in CBS vs. controls
- Total tau: Elevated in some patients, especially with AD pathology
- Phospho-tau: May be elevated in tau-predominant CBS
Early PD can mimic prodromal CBS:
- Asymmetric onset common to both
- However, PD typically has better levodopa response
- REM sleep behavior disorder more common in PD
Overlap syndromes are common:
- Early falls and vertical gaze palsy suggest PSP
- CBS-PSP overlap is well-documented pathologically
- Pure prodromal CBS may lack PSP features
Early AD can present similarly:
- Memory complaints prominent in AD
- Posterior cortical atrophy pattern differs from CBS
- Biomarkers (amyloid) help differentiate
FTD and CBS share features:
- Behavioral variant FTD may precede CBS features
- Language variant FTD can evolve to CBS
- GRN mutations cause both phenotypes
- Detailed history: Focus on symptom onset and progression
- Cognitive testing: Formal neuropsychological evaluation
- Motor examination: Look for asymmetric findings
- Neurological exam: Including alien limb testing
Recommended workup:
- Structural MRI with volumetric analysis
- FDG-PET or tau PET if available
- CSF analysis (tau, NfL, amyloid)
- Genetic testing if family history
Current criteria require presence of:
- Progressive asymmetric parkinsonism OR
- Cortical dysfunction (apraxia, cortical sensory loss) PLUS
- At least one of: alien limb, myoclonus, aphasia
Prodromal CBS lacks sufficient features for definite diagnosis.
- Early identification allows for:
- Advanced care planning
- Medication adjustment before major disability
- Clinical trial enrollment
- Family education and support
- Symptomatic treatment: May include dopaminergic medications
- Neuroprotective strategies: Exercise, cognitive stimulation
- Safety measures: Driving assessment, fall prevention
- Support services: Early connection with support groups
- Blood-based markers: NfL, p-tau217, p-tau181
- Digital biomarkers: Wearable sensors for subtle motor changes
- Electrophysiology: EEG signatures of cortical dysfunction
- Analysis of pre-diagnosis clinical records
- Review of imaging for early patterns
- Genetic carriers followed longitudinally
- Ling et al., Prodromal CBS clinical features (2010)
- Armstrong et al., CBS diagnostic criteria (2013)
- Sakae et al., CBS pathological subtypes (2021)
- Jabbari et al., CBS prodromal biomarkers (2021)
- Kobylecki et al., CBS genetic predictors (2018)
- Stamelou et al., CBS overlapping syndromes (2022)